Predicting Psychopathological Onset: Early Signs of Neuropsychiatric Diseases
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Mechanisms of Diseases".
Deadline for manuscript submissions: closed (10 December 2021) | Viewed by 70797
Special Issue Editor
Special Issue Information
Dear Colleagues,
Millions of people worldwide are affected by neuropsychiatric disorders, such as anxiety, major depression, bipolar disorder, schizophrenia, obsessive-compulsive disorder, autism spectrum disorder (ASD), attention-deficit/hyperactivity disorder, and post-traumatic stress disorder. Although clinical tools are valuable in treating psychopathologies, the identification of early signs of psychopathology remains a main target to be reached in order to improve treatment effectiveness and reduce poor outcomes.
The assessment of biological, behavioural, and cognitive markers of psychopathology could provide a significant support in pre-clinical phases to identify vulnerability factors, understand the course of illness and predict its outcome, as well as aid clinicians in the therapeutic decision-making process.
In this Special Issue of the Journal of Personalized Medicine, papers addressing early markers of psychopathology aimed at improving diagnostic tools and at envisaging personalized therapies are welcome.
Prof. Marco Costanzi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Genomics
- Epigenomics
- Neurophysiology
- Behavioral signs
- Cognitive abnormalities
- Neuropsychiatric disorders
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.